Publication | Closed Access

Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome

InflammationSleepAnti-inflammatoryOxysterolMedicineNew Therapeutic TargetLipid PeroxidationImmunologyEndothelial DysfunctionCysteinyl-leukotriene PathwayVascular BiologySleep ApneaPharmacologyAtherosclerosisSleep Disordered BreathingOxidative StressSleep-related Breathing Disorder